As more and more states relax laws restricting the use of medical marijuana, Neutra Corp. (OTCBB: NTRR), an innovator in natural solutions for living a healthier, happier life, is considering highly promising new opportunities on the technology and support side of the budding industry.
Nationwide, the tide appears to be turning in favor of medicinal cannabis. That means big business for companies well-positioned to capitalize on changes in legislation. Medical Marijuana, Inc. (OTC: MJNA), an industry leader, recently reported earnings of approximately $1.47 million on gross revenues of $2.40 million for the quarter ended June 30, 2012. That’s a gross revenue increase of 1,200 percent quarter-over-quarter when compared to revenue of $196,748 for the quarter that ended June 30, 2011.
“The medical marijuana industry is growing at a lightning-fast pace in markets all over the country, and we need additional manpower to fully capitalize on that growth,” Morrissey said. “We’ve already made plans to visit potential targets in California and possibly Colorado before the end of April. We are investigating new methods of product delivery aimed at a broader market as well as potential partnerships with cutting-edge research and development companies with innovative ideas.”
Since 1996, 18 states and the District of Columbia have approved marijuana for medical usage, and the number is growing. Last year, Colorado and Washington passed laws legalizing the use of marijuana. Bills to legalize medical cannabis dispensaries are now on the table in Oregon and Nevada, two states that have had MMJ laws on the books for years but currently don’t allow storefront businesses. This week in New Hampshire, state representatives passed a bill in support of establishing a New Hampshire program.Neutra Corp. is dedicated to commercializing innovative, all-natural products to compete in the fast-growing medical marijuana sector alongside Cannabis Science Inc. (PINK: CBIS), Medical Marijuana Inc. (PINK: MJNA), HEMP Inc. (PINK: HEMP) and Growlife Inc. (OTC: PHOT).
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts